DIAMEDICA THERAPEUTICS Aktie - Unternehmensdaten & Kurse - CA25253X2077 | MoneyPeak

DIAMEDICA THERAPEUTICS

Share · CA25253X2077 · DMAC · A2N9HB (XFRA)

No Price

17.09.2025 16:30

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

0

6

0

0

0

Current Prices from DIAMEDICA THERAPEUTICS

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	DMAC	USD	17.09.2025 16:30	7,06 USD	0,09 USD +1,29 %

ESG Risk Rating

B Good

Share Float & Liquidity

Free Float 43,80 %

Shares Float 22,64 M

Shares Outstanding 51,69 M

Company Profile for DIAMEDICA THERAPEUTICS Share

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic stroke. It is also developing DM300 that is in pre-clinical stage for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Company Data

Name DIAMEDICA THERAPEUTICS

Company DiaMedica Therapeutics Inc.

Symbol DMAC

Website https://www.diamedica.com

Primary Exchange

Frankfurt

WKN A2N9HB

ISIN CA25253X2077

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Dietrich John Pauls MBA

Market Capitalization 267 Mio

Country United States of America

Currency EUR

Employees 0,0 T

Address Two Carlson Parkway, 55447 Minneapolis

IPO Date 2012-08-03

Stock Splits

Date	Split
15.11.2018	1:20

Ticker Symbols

Name	Symbol
NASDAQ	DMAC

More Shares

Investors who hold DIAMEDICA THERAPEUTICS also have the following shares in their portfolio:

BAIDU INC. 21/31 Bond

New Providence Acquisition Corp. II - Unit Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025